Rapid quantitation of erythropoietin and identification of its glycans using membranes for capture and digestion
Erythropoietin (EPO) is a glycoprotein hormone used to treat chronic anemia. Glycans at the three N-glycosylation sites strongly influence EPO's stability and bioactivity, so accurate quantitation of EPO and analysis of its glycosylation patterns are critical during production and subsequent processing. This work demonstrates a rapid workflow for EPO capture, quantitation, and glycan profiling. Newly developed porous membranes containing affinity peptides selectively capture EPO from cell culture supernatants. In a 96-well-plate format, captured EPO was labeled with a fluorescent antibody to enable quantitation in a 10-min assay with an average coefficient of variation of 12 %. Elution of captured EPO from a 2-cm glass-fiber membrane combined with tryptic membranes enabled efficient purification and digestion for liquid chromatography-tandem mass spectrometry (LC-MS/MS) glycan analysis. Without purification, conventional LC-MS/MS identification of EPO N-glycans in Chinese hamster ovary (CHO) cell supernatant was not possible. The rapid in-membrane digestion yielded glycan profiles comparable to those obtained from overnight in-solution digestion. Thus, the membrane-based assays provide a novel approach for rapid EPO quantitation and facilitating glycan identification.
Authors
- Nicholas E. Manicke (ORCID: https://orcid.org/0000-0002-2296-0497)
- Junyan Yang (ORCID: https://orcid.org/0000-0002-6689-1059)
- Bill Boggess
- Yuhang Chen
- Merlin L. Bruening
Institutions
- University of Notre Dame (US)
- University of Indianapolis (US)
- Indianapolis Zoo (US)
- Indiana University – Purdue University Indianapolis (US)
Publication Details
- Journal
- Talanta
- Published
- 2026-01-13
- DOI
- https://doi.org/10.1016/j.talanta.2026.129396
- Primary Topic
- Erythropoietin and Anemia Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00